IP Library Granted Patent US 6,869,610
Granted Patent B2
US 6,869,610 · App. 10/199,222 · Granted Mar 22, 2005

Pain treatment by peripheral administration of a neurotoxin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,869,610
App. No.
10/199,222
Granted
Mar 22, 2005
Kind
B2
Abstract

Methods for treating a non-spasm caused pain by peripheral administration to a patient of a therapeutically effective amount of a neurotoxin, such as a botulinum toxin.

Claims (7)

1. A method for alleviating neuralgia, the method comprising the step of peripheral administration of an effective amount of a botulinum toxin to a human patient for a time effective to alleviate neuralgia pain, wherein the pain treated is not associated with a headache.

2. The method of claim 1 , wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C 1 , D, E, F and G.

3. The method for alleviating neuralgia, the method comprising the step of peripheral administration of an effective amount of the botulinum toxin type A to a human patient for a time effective to alleviate neuralgia pain, Wherein the pain treated is not associated with a headache.

4. A method for treating pain that occurs after a surgical procedure, the method comprising the step of peripheral administration of an effective amount of a botulinum toxin before, during or immediately after a surgical procedures wherein the surgical procedure is not carried out to treat a muscle spasm and wherein the surgical procedure is selected from the group consisting of a tumor removal, a bone graft, a bone replacement, an exploratory surgery, a wound closure, a cosmetic surgery, a dermal incision and a non-muscle disorder treatment surgical procedure.

5. A method for treating pain that occurs after a surgical procedure, the method comprising the step of peripheral administration of an effective amount of a botulinum toxin type A before, during or immediately after a surgical procedure, wherein the surgical procedure is not carried out to treat a muscle spasm and wherein the surgical procedure is selected from the group consisting of a tumor removal, a bone graft, a bone replacement, an exploratory surgery, a wound closure, a cosmetic surgery, a dermal incision and a non-muscle disorder treatment surgical procedure.

6. A method for treating visceral pain the method comprising the step of non-systemic, local administration of an effective amount of a botulinum toxin, thereby alleviating a visceral pain, wherein the visceral pain is selected from the group consisting of abdominal, a digestive system pain, a respiratory system pain, a urogenital system pain, an endocrine system pain, a spleen pain, a heart pain, a vessel pain, a pancreatic pain, an intestinal pain, and a stomach pain, and wherein the pain treated is not associated with a headache.

7. A method for treating visceral pain the method comprising the step of non-systemic, local administration of an effective amount of a botulinum toxin type A, thereby alleviating a visceral pain, wherein the visceral pain is selected from the group consisting of abdominal pain, a digestive system pain, a respiratiory system pain, a urogenital system pain, an endocrine systems pain, a spleen pain, a heart pain, a vessel pain, a pancreatic pain, an intestinal pain, and a stomach pain, and wherein the pain treated is not assciated with a headache.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2003
From: ALLERGAN SALES, INC. (MERGED INTO ALLERGAN SALES, LLC 6/3/2002)
To: ALLERGAN, INC.
Reel/Frame 013898/0170 →